It happens because Semaglutide mimics a hormone called GLP-1 (glucagon-like peptide-1), which helps regulate appetite and slows digestion in the first week or two
Recent studies indicate that weight rebound after drug discontinuation is delayed with the newer, more effective GLP-1 mimetics, he said
Cardiometabolic research (hypertension, dyslipidemia, cardiovascular diseases): Investigated for its beneficial effects on blood pressure, lipid metabolism, and cardiovascular outcomes, including the reduction of major adverse cardiovascular events in patients with type 2 diabetes and obesity
You have an active cancer (due to angiogenesis stimulation)
doi: 10.1016/j.dsx.2019.03.018 163 JanssenAMBosmanCBvan DuijnWOostendorp-van de RuitMMKubbenFJGriffioenGet al
Polyphenols and human health: the role of bioavailability